Australian-owned supplier
New JAMA Study Links Wegovy to NAION A JAMA study published on July 3, 2024, on the Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide found an increased risk of the condition in patients taking semaglutide compared to those taking non-GLP-1 RA medications
In 2023, the American Society of Anaesthesiologists published a statement that short-acting GLP-1 receptor agonists should be discontinued for one day, and long-acting GLP-1 receptor agonists for one week prior to elective procedures
It was investigated by the Australian pharmaceutical company Metabolic Pharmaceuticals specifically for obesity treatment in the early 2000s
Anand, P., Rajakumar, D., Jeraud, M., Felix, A
Comfortable wear: Experience weightless hydration without feathering or bleeding